Green fluorescent proteins have been floating in the ocean for more than 160 million years, but it took a curious scientist, fascinated by pinpricks of green light, to begin unlocking their potential.
Much has been written about the basic incompatibility of the dominant quantitative research model in psychotherapy and the qualitative preferences of the practitioner community providing psychotherapy.
With the constant exchange of international information now a permanent condition in the world, social work scholars and students must be sensitive to the need for knowledge sharing between countries as well as to issues involved in obtaining and utilizing international knowledge.
Nancy Andreasen, a leading neuroscientist who is also Editor-in-Chief of the prestigious American Journal of Psychiatry as well as the winner of the illustrious National Medal of Science, offers here a state-of-the-art look at what we know about the human brain and the human genome--and shows how these two vast branches of knowledge are coming together in a boldly ambitious effort to conquer mental illness.
Tissue or organ transplantation are among the few options available for patients with excessive skin loss, heart or liver failure, and many common ailments, and the demand for replacement tissue greatly exceeds the supply, even before one considers the serious constraints of immunological tissue type matching to avoid immune rejection.
Screening programmes involve the systematic offer of testing for populations or groups of apparently healthy people to identify individuals who may be at future risk of a particular medical condition or disease, with the aim of offering intervention to reduce their risk.
Screening programmes involve the systematic offer of testing for populations or groups of apparently healthy people to identify individuals who may be at future risk of a particular medical condition or disease, with the aim of offering intervention to reduce their risk.
Now in its Fourth Edition, An Introduction to Medical Statistics continues to be a 'must-have' textbook for anyone who needs a clear logical guide to the subject.
The Oxford Handbook of Clinical and Healthcare Research is an evidence-based, succinct, and easy-to-use reference for the full range of clinical and healthcare research topics.
The study of the biology of tumours has grown to become markedly interdisciplinary, involving chemists, statisticians, epidemiologists, mathematicians, bioinformaticians, and computer scientists alongside biologists, geneticists, and clinicians.
The study of the biology of tumours has grown to become markedly interdisciplinary, involving chemists, statisticians, epidemiologists, mathematicians, bioinformaticians, and computer scientists alongside biologists, geneticists, and clinicians.
A good understanding of medical statistics is essential to evaluate medical research and to choose appropriate ways of implementing findings in clinical practice.
A good understanding of medical statistics is essential to evaluate medical research and to choose appropriate ways of implementing findings in clinical practice.
The Oxford Handbook of Clinical and Healthcare Research is an evidence-based, succinct, and easy-to-use reference for the full range of clinical and healthcare research topics.
The research-practice gap is a persistent problem in healthcare - significant new knowledge is created but only some of it is shared and even less is used.
This second edition of the Oxford Handbook of Key Clinical Evidence provides an alternative to the growing volumes of trial data for students, trainees and researchers looking for the key evidence affecting medical practice.
This second edition of the Oxford Handbook of Key Clinical Evidence provides an alternative to the growing volumes of trial data for students, trainees and researchers looking for the key evidence affecting medical practice.
In examining the relationship between nutritional exposure and disease aetiology, the importance of a carefully considered experimental design cannot be overstated.
Despite the phenomenal clinical success of antibody-based biopharmaceuticals in recent years, discovery and development of these novel biomedicines remains a costly, time-consuming, and risky endeavor with low probability of success.
